In the Shadow of COVID-19, Will Other Vaccine Development Programs Be Left Behind?

As governments around the world ramp up COVID-19 prevention activities, are other diseases of international importance and their prevention programs suddenly on pause?

Plasma-Derived ApoA-1

Findings suggest CSL112 can boost cholesterol efflux capacity in patients with impaired endogenous HDL function. Encouragingly, several studies have documented its ability to reduce atherosclerotic plaque volume.

Myths & Facts: Chronic Inflammation

This elusive condition often goes undetected, and when left untreated, it can contribute to a host of serious health risks.

Childhood Obesity: An Expanding Epidemic

With the childhood obesity epidemic escalating, pediatricians can help to prevent and treat it.

Tailor-Made Medicine: An Evolution in Precision Cures

With big data and artificial intelligence, there is great hope for tailor-made medicine, but there are challenges that must be overcome.

Evolving from Sick Care to Well Care

Embracing a preventive healthcare model can help to reduce spending and improve patient outcomes, but it will require a seismic shift in mindset by patients, providers and payers.

The Changing Face of Primary Care

How health systems and providers are adapting to new dynamics and demands in primary care.

Myths & Facts: Bipolar Spectrum Disorder

A great deal of stigma surrounds this disorder due to a misunderstanding of what it is and how effectively it can be treated and managed.

Update on Anaphylaxis

Responding to the growing number of people affected by food allergy anaphylaxis, researchers are
seeking ways to reduce the risk and severity of this condition.

Establishing an Antimicrobial Stewardship Program

The adoption of ASPs has resulted in a reduction of antimicrobial expenditures, but stopping the tide of multidrug-resistant organisms depends on leadership’s commitment to track data down to the patient level.